Phase 4 Amyloidosis Clinical Trials

5 recruitingPhase 4

What is a Phase 4 trial?

Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.

Showing 1–5 of 5 trials

Recruiting

Phase 4

Real-Life Clinical Efficacy of Acoramidis in Participants With ATTR-CM and Association With Cardiac Biomarkers

Transthyretin-type Cardiac Amyloidosis

Alexion Pharmaceuticals, Inc.200 enrolled16 locationsNCT07306949

Recruiting

Phase 4

Ultrasound Therapy In Cardiac Amyloidosis

Amyloidosis Cardiac

Brigham and Women's Hospital70 enrolled1 locationNCT04667494

Recruiting

Phase 4

Safety, Efficacy, and Pharmacokinetics of Tafamidis in Patients With Transthyretin-mediated Amyloidosis Post Orthotopic Heart Transplantation

Transthyretin Cardiac Amyloidosis

University of Texas Southwestern Medical Center25 enrolled4 locationsNCT05489523

Recruiting

Phase 4

A Prospective Cohort Study on Primary Cutaneous Amyloidosis

Primary Cutaneous Amyloidosis

Army Medical University, China56 enrolled1 locationNCT06998875

Recruiting

Phase 4

Clinical Study of ATTR-CM

Transthyroxine Amyloidosis Cardiomyopathy

Second Affiliated Hospital, School of Medicine, Zhejiang University100 enrolled1 locationNCT04935021